|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.06.26 - 15:03
|
Stock Futures Flat As S&P Closes Out Best Quarter In 6 Years (ZeroHedge)
|
|
|
Stock Futures Flat As S&P Closes Out Best Quarter In 6 Years
US index futures erased an earlier gain following some belligerent Iran headlines, but are still set to end a quarter that is set to be the S&P 500's best in six years with markets behaving as though period-end dynamics have now completed. As of 8:30am, the S&P 500 was flat, pointing to a calm finish for the index that has surged 14% since the beginning of April. Nasdaq futures rose 0.1% erasing a sizable gain earlier, but on pace to close the quarter with a staggering 24% gain; In premarket trading, semis are mixed, Mag7 are flat, Cyclicals are generally leading Defensives with exceptions being Energy (lower) and Healthcare (higher). European stocks rallied, with gains led by Abivax SA after a clinical-trial update soothed investor concerns. Chipmakers drove Asian shares higher. JPM says with the major US holiday coming up, keep an eye on low liquidity moves in the region. Bond yields reversed an earlier drop to trade higher by 1b...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.06.26 - 09:15
|
Abivax-Aktie: Neue Daten da – das ist die Erlösung! (Sharedeals)
|
|
|
Die Aktie des französischen Biotechnologieunternehmens Abivax erlebt einen regelreichten Beifreiungsschlag und gewann nachbörslich zeitweise um mehr als 25% hinzu. Auslöser sind neue, erweiterte Daten aus dem klinischen Phase-2- und Phase-3-Programm des Hoffnungsträgers Obefazimod zur Behandlung von Colitis ulcerosa, die ein zuvor kontrovers diskutiertes Sicherheitsthema weitgehend entschärfen. Sicherheitsprofil bestätigt Erwartungen Im Mittelpunkt der aktuellen Veröffentlichung steht […]
The post Abivax-Aktie: Neue Daten da – das ist die Erlösung! first appeared on sharedeals.de....
|
|
|
|
|
|
|
|